Business2 months ago
Novartis Faces Transition Year Ahead, Downgrades Rating to Neutral
Novartis has officially transitioned into a pure-play innovative medicines company, marking a significant shift following the recent spin-offs of Alcon and Sandoz. As a result, the...
